Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models 20737496 322, 03261638 190, and 11822713 226
Diazo Colorimetry, Bilirubin. 510(k) K063543, from Roche Diagnostics Corp. (Indianapolis, IN). Product code CIG, class 2.
As of Nov 19, 2026, K063543 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Dec 22, 2006 after 28 days, with no recalls tied to it in FDA's recall database.
- Review time: 28 days
- Recalls: 0
- Cited as a predicate by: 3 devices
COBAS INTEGRA Bilirubin Direct The cassette COBAS INTEGRA Bilirubin Direct (BIL-D) contains an in vitro diagnostic reagent system intended for use on COBAS INTEGRA systems for the quantitative determination of the direct (conjugated) bilirubin concentration in serum and plasma (test BIL-D, 0-049).
- Roche Cobas Integra Analyzer, Reagent CassettesK951595 · Roche Diagnostic Systems, Inc. · Sep 8, 1995
- Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin ReagentK981632 · Roche Diagnostics/Boehringer Mannheim GmbH · Jun 15, 1998
- Cobas C Bilirubin Total GEN.3K131544 · Roche Diagnostics · Jul 17, 2013
- Cobas Integra Bilirubin Direct GEN.2K123965 · Roche Diagnostics · Feb 28, 2013
- Cobas Integra C 111K063744 · Rochdiag · Jan 17, 2007
- Atellica CH Diazo Total Bilirubin (D_TBil)K251998 · Siemens Healthcare Diagnostics, Inc. · Feb 27, 2026
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 24, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files